These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 8474004)

  • 1. Characterization of vascular postsynaptic neuropeptide Y receptor function and regulation. 1. NPY-induced constriction in isolated rat femoral artery rings is mediated by both Y1 and Y2 receptors: evidence from benextramine protection studies.
    Tessel RE; Miller DW; Misse GA; Dong X; Doughty MB
    J Pharmacol Exp Ther; 1993 Apr; 265(1):172-7. PubMed ID: 8474004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrimination by benextramine between the NPY-Y1 receptor subtypes present in rabbit isolated vas deferens and saphenous vein.
    Palea S; Corsi M; Rimland JM; Trist DG
    Br J Pharmacol; 1995 May; 115(1):3-10. PubMed ID: 7647980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular neuropeptide Y Y1-receptors in the rat kidney: vasoconstrictor effects and expression of Y1-receptor mRNA.
    Modin A; Malmström RE; Meister B
    Neuropeptides; 1999 Aug; 33(4):253-9. PubMed ID: 10657500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of neuropeptide Y and [Leu31,Pro34] neuropeptide Y on experimental gastric lesion formation and gastric secretion in the rat.
    Penner SB; Smyth DD; Glavin GB
    J Pharmacol Exp Ther; 1993 Jul; 266(1):339-43. PubMed ID: 8101219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries.
    You J; Edvinsson L; Bryan RM
    J Cereb Blood Flow Metab; 2001 Jan; 21(1):77-84. PubMed ID: 11149671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.
    Malmström RE
    Acta Physiol Scand Suppl; 1997; 636():1-55. PubMed ID: 9179320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y modulates the vascular response to periarterial nerve stimulation primarily by a postjunctional action in the isolated perfused rat kidney.
    Oellerich WF; Malik KU
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1321-9. PubMed ID: 8371140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of the putative neuropeptide Y antagonists, benextramine and PYX-2, to inhibit Y2 receptors in rat isolated prostatic vas deferens.
    Palea S; Corsi M; Rimland JM; Trist DG; Ratti E
    Br J Pharmacol; 1995 Nov; 116(5):2401-6. PubMed ID: 8581275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonpeptide peptidomimetic antagonists of the neuropeptide Y receptor: benextramine analogs with selectivity for the peripheral Y2 receptor.
    Chaurasia C; Misse G; Tessel R; Doughty MB
    J Med Chem; 1994 Jul; 37(14):2242-8. PubMed ID: 7913507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
    Kask A; Rägo L; Harro J
    Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of vascular postsynaptic NPY receptor function and regulation and differential sensitivity of Y1 and Y2 receptor function to changes in extracellular calcium availability and prior in vitro peptide exposure.
    Tessel RE; Miller DW; Misse GA; Dong X; Doughty MB
    Neuropeptides; 1993 Nov; 25(5):289-98. PubMed ID: 7509465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors.
    Dimitrijević M; Stanojević S; Vujić V; Beck-Sickinger A; von Hörsten S
    Regul Pept; 2005 Jan; 124(1-3):163-72. PubMed ID: 15544855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible location and function of neuropeptide Y receptor subtypes in the rat mesenteric arterial bed.
    McAuley MA; Westfall TC
    J Pharmacol Exp Ther; 1992 Jun; 261(3):863-8. PubMed ID: 1351098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of neuropeptide Y Y1 receptors inhibits glutamate release through reduction of voltage-dependent Ca2+ entry in the rat cerebral cortex nerve terminals: suppression of this inhibitory effect by the protein kinase C-dependent facilitatory pathway.
    Wang SJ
    Neuroscience; 2005; 134(3):987-1000. PubMed ID: 16026936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
    Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
    Silva AP; Carvalho AP; Carvalho CM; Malva JO
    Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension.
    Wiest R; Jurzik L; Moleda L; Froh M; Schnabl B; von Hörsten S; Schölmerich J; Straub RH
    J Hepatol; 2006 Mar; 44(3):512-9. PubMed ID: 16324766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
    Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
    Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased brain neuropeptide Y1 and Y2 receptor binding in NPY knock out mice does not result in increased receptor function.
    Gehlert DR; Shaw JL
    Peptides; 2007 Feb; 28(2):241-9. PubMed ID: 17208335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
    Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
    Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.